Cancer Research after COVID-19: Where Do We Go from Here?
- PMID: 32396859
- PMCID: PMC7212941
- DOI: 10.1016/j.ccell.2020.04.003
Cancer Research after COVID-19: Where Do We Go from Here?
References
-
- FDA News Release Coronavirus (COVID-19) update: FDA issues guidance for conducting clinical trials. 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... News release from the U.S. Food and Drug Administration. (accessed April 6, 2020)
-
- Feuerstein A. Amid coronavirus, disruptions to clinical trial, drug development accelerate. STAT. 2020 https://www.statnews.com/2020/03/23/as-covid-19-spreads-disruptions-to-c... (accessed April 5, 2020)
-
- Joseph A. Coronavirus pandemic forces some research labs to shut down. STAT. 2020 https://www.statnews.com/2020/03/14/coronavirus-pandemic-forces-research... (accessed April 5, 2020)
-
- Ledford H. Coronavirus shuts down trials of drugs for multiple other diseases. Nature. 2020;580:15–16. - PubMed
-
- Editorial Safeguard research in the time of COVID-19. Nat. Med. 2020;26:443. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
